Related Experiment Video
Updated: Dec 6, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
ANO3 and early-onset dyskinetic encephalopathy
Ana Jiménez de Domingo1, Sara Lopez-Martín2, Jacobo Albert3
1Department of Pediatric Neurology, Hospital Universitario Quirónsalud, Madrid, Spain.
New ANO3 gene mutations are linked to a rare disorder causing early psychomotor regression and dystonia in a young child. This finding expands understanding of ANO3-related neurological conditions.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Mutations in the ANO3 gene are linked to autosomal dominant craniocervical dystonia.
- Limited information exists on the genotype-phenotype characteristics of ANO3-related disorders.
- Understanding these genetic links is crucial for diagnosing and managing rare neurological conditions.
Observation:
- A 3-year-old girl presented with distal myoclonic dystonia.
- Whole exome sequencing identified a novel de novo missense ANO3 variant.
- Global psychomotor regression was observed concurrently with dystonia onset.
Findings:
- Brain MRI revealed normal findings at 18 months.
- Progressive mild brain and cerebellar atrophy were noted 18 months later.
- The novel ANO3 variant is associated with a complex neurodevelopmental disorder.
Implications:
- Missense mutations in ANO3 may contribute to complex disorders involving early psychomotor regression and dystonia.
- This case highlights the importance of genetic analysis in pediatric movement disorders.
- Further research into ANO3 variants could reveal new therapeutic targets for dystonia.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antiepileptic Drugs: Glutamate Antagonists